Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease

被引:78
作者
Kurotobi, S
Kawakami, N
Shimizu, K
Aoki, H
Nasuno, S
Takahashi, K
Kogaki, S
Ozono, K
机构
[1] Osaka Univ, Grad Sch Med, Dept Dev Med Pediat, Suita, Osaka 5650871, Japan
[2] Toyonaka City Hosp, Dept Pediat, Toyonaka, Osaka 5608565, Japan
关键词
Kawasaki disease; BNP; diastolic function; echocardiography;
D O I
10.1007/s00246-004-0812-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although an increased level of serum brain natriuretic peptide (BNP) has been reported in children in the acute phase of Kawasaki disease (KD), no precise relation was documented between the serum BNP level and left ventricular (LV) systolic function. We hypothesized that the increased BNP levels may be explained by diastolic abnormalities in those with KD. We prospectively studied 25 patients in the acute phase of KD. Patients with abnormal systolic function were excluded. Pediatric cardiologists making the assessment of LV diastolic function were blinded to the BNP levels. Doppler interrogation was applied to measure LV inflow velocities, which were transformed to z scores using control measurements obtained from 83 healthy subjects. In the patients, the BNP levels ranged from 2.0 to 450.0 pg/ml, with a mean of 54.0 +/- 102.8 pg/ml. Six patients with abnormal velocities (> 2 SD in z score) showed significantly higher levels of BNP (152 173 pg/ml) than those in the remaining patients (p < 0.01). The BNP levels correlated positively with diastolic atrial velocity in z score (r = 0.51, p < 0.05), and negatively with diastolic early velocity to atrial velocity ratio in z score (r = -0.75, p < 0.01). This study suggests that LV diastolic dysfunction may occur in some children in the acute phase of KD, causing an increased level of BNP.
引用
收藏
页码:425 / 430
页数:6
相关论文
共 19 条
[1]  
BULOCK FA, 1995, BRIT HEART J, V73, P334
[2]   ROLE OF AGE ON TRANSMITRAL FLOW VELOCITY PATTERNS IN ASSESSING LEFT-VENTRICULAR DIASTOLIC FUNCTION IN NORMAL INFANTS AND CHILDREN [J].
HARADA, K ;
SUZUKI, T ;
TAMURA, M ;
ITO, T ;
TAKAHASHI, Y ;
SHIMADA, K ;
TAKADA, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (07) :530-&
[3]   Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease [J].
Kawamura, T ;
Wago, M ;
Kawaguchi, H ;
Tahara, M ;
Yuge, M .
PEDIATRICS INTERNATIONAL, 2000, 42 (03) :241-248
[4]   Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease [J].
Kawamura, T ;
Wago, M .
CARDIOLOGY IN THE YOUNG, 2002, 12 (02) :153-158
[5]   Heart failure and neuroendocrine activation:: diagnostic, prognostic and therapeutic perspectives [J].
Kjær, A ;
Hesse, B .
CLINICAL PHYSIOLOGY, 2001, 21 (06) :661-672
[6]   Normal values of B type natriuretic peptide in infants, children, and adolescents [J].
Koch, A ;
Singer, H .
HEART, 2003, 89 (08) :875-878
[7]   BRAIN NATRIURETIC PEPTIDE AS A CARDIAC HORMONE IN ESSENTIAL-HYPERTENSION [J].
KOHNO, M ;
HORIO, T ;
YOKOKAWA, K ;
MURAKAWA, KI ;
YASUNARI, K ;
AKIOKA, K ;
TAHARA, A ;
TODA, I ;
TAKEUCHI, K ;
KURIHARA, N ;
TAKEDA, T .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (01) :29-34
[8]   Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase [J].
Ma, KK ;
Ogawa, T ;
de Bold, AJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (04) :505-513
[9]   Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction [J].
Maeda, K ;
Tsutamoto, T ;
Wada, A ;
Hisanaga, T ;
Kinoshita, M .
AMERICAN HEART JOURNAL, 1998, 135 (05) :825-832
[10]  
Matsubara T, 1991, Arerugi, V40, P147